Form 8-K - Current report:
SEC Accession No. 0001048477-20-000004
Filing Date
2020-02-26
Accepted
2020-02-26 16:10:49
Documents
16
Period of Report
2020-02-26
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bmrn-20200226.htm   iXBRL 8-K 42761
2 EX-99.1 bmrn-20xfeb26xex991.htm EX-99.1 839474
8 bmrnlogoa011.jpg GRAPHIC 3615
  Complete submission text file 0001048477-20-000004.txt   1071692

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bmrn-20200226.xsd EX-101.SCH 2661
4 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bmrn-20200226_cal.xml EX-101.CAL 803
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bmrn-20200226_def.xml EX-101.DEF 1767
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bmrn-20200226_lab.xml EX-101.LAB 24265
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bmrn-20200226_pre.xml EX-101.PRE 12739
14 EXTRACTED XBRL INSTANCE DOCUMENT bmrn-20200226_htm.xml XML 10765
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

EIN.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-26727 | Film No.: 20655775
SIC: 2834 Pharmaceutical Preparations